tiprankstipranks
Advertisement
Advertisement

GB:TCF Stock Latest News

TheraCryf to Host Investor Webinar as Lead Addiction Drug Nears Clinical Stage
Company AnnouncementsTheraCryf to Host Investor Webinar as Lead Addiction Drug Nears Clinical Stage
17d ago
TheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
PremiumCompany Announcements
TheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
18d ago
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
PremiumCompany Announcements
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
22d ago
TheraCryf Rejects Bid for Lead Neuropsychiatry Assets, Backs In-House Growth Strategy
PremiumCompany Announcements
TheraCryf Rejects Bid for Lead Neuropsychiatry Assets, Backs In-House Growth Strategy
24d ago
TheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone
PremiumCompany Announcements
TheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone
2M ago
TheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage
PremiumCompany AnnouncementsTheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage
3M ago
TheraCryf Hits Key Manufacturing Milestone for Ox-1 Addiction Candidate
Premium
Company Announcements
TheraCryf Hits Key Manufacturing Milestone for Ox-1 Addiction Candidate
4M ago
TheraCryf Announces Progress on Preclinical Fatigue Treatment Program
Premium
Company Announcements
TheraCryf Announces Progress on Preclinical Fatigue Treatment Program
5M ago
TheraCryf Advances Addiction Treatment Program with Strategic Developments
PremiumCompany Announcements
TheraCryf Advances Addiction Treatment Program with Strategic Developments
5M ago
TheraCryf Advances Ox-1 Program Amidst Addiction Awareness Week
PremiumCompany Announcements
TheraCryf Advances Ox-1 Program Amidst Addiction Awareness Week
5M ago
TheraCryf Advances Addiction Treatment Program Amidst Awareness Week
PremiumCompany Announcements
TheraCryf Advances Addiction Treatment Program Amidst Awareness Week
5M ago
TheraCryf plc to Announce Half-Year Results on 3 December 2025
PremiumCompany Announcements
TheraCryf plc to Announce Half-Year Results on 3 December 2025
5M ago
TheraCryf Achieves Key Milestone in Ox-1 Addiction Program
PremiumCompany AnnouncementsTheraCryf Achieves Key Milestone in Ox-1 Addiction Program
6M ago
TheraCryf Director Increases Stake, Signaling Confidence in Strategic Direction
Premium
Company Announcements
TheraCryf Director Increases Stake, Signaling Confidence in Strategic Direction
7M ago
TheraCryf Highlights Mental Health Initiatives and Q4 Conference Plans
Premium
Company Announcements
TheraCryf Highlights Mental Health Initiatives and Q4 Conference Plans
7M ago
TheraCryf Secures Korean Patent and Advances Ox-1 Development
PremiumCompany Announcements
TheraCryf Secures Korean Patent and Advances Ox-1 Development
8M ago
TheraCryf Advances Ox-1 Development with Manufacturing Scale-Up
PremiumCompany Announcements
TheraCryf Advances Ox-1 Development with Manufacturing Scale-Up
10M ago
TheraCryf plc Successfully Passes All Resolutions at AGM
PremiumCompany Announcements
TheraCryf plc Successfully Passes All Resolutions at AGM
10M ago
TheraCryf plc Reports Significant Progress in Drug Development Programs
PremiumCompany Announcements
TheraCryf plc Reports Significant Progress in Drug Development Programs
10M ago
TheraCryf plc Releases Annual Report and Announces AGM
PremiumCompany AnnouncementsTheraCryf plc Releases Annual Report and Announces AGM
11M ago
TheraCryf Appoints New Adviser to Boost Market Position
Premium
Company Announcements
TheraCryf Appoints New Adviser to Boost Market Position
11M ago
TheraCryf to Host Investor Webinar on Ox-1 Program
Premium
Company Announcements
TheraCryf to Host Investor Webinar on Ox-1 Program
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >